CAPE may be able to ameliorate Parkinson’s disease in PD murine models, attenuating dopaminergic loss and decreasing behavioral abnormality through oxidative stress and reducing neuroinflammation, causing a protective effect on nigral dopaminergic neurons by HO-1-dependent MAPK signaling [83,84]. The gene discussed is HMOX1; the disease is Parkinson disease.